PICTET ASSET MANAGEMENT SA - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 156 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.2%.

Quarter-by-quarter ownership
PICTET ASSET MANAGEMENT SA ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$8,418,739
-23.1%
393,399
+45.2%
0.01%
-28.6%
Q1 2023$10,953,295
+322720.4%
270,853
+271.4%
0.01%
+180.0%
Q4 2022$3,393
-99.9%
72,937
+34.8%
0.01%
+25.0%
Q3 2022$2,806,000
+100.3%
54,097
+82.6%
0.00%
+100.0%
Q2 2022$1,401,00029,6290.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 1,599,109$63,277,0008.68%
SENZAR ASSET MANAGEMENT, LLC 566,903$22,432,0006.58%
Sarissa Capital Management LP 105,000$4,155,0001.60%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 136,637$5,407,0001.41%
RA Capital Management 250,000$9,893,0001.17%
BENNETT LAWRENCE MANAGEMENT L L C/NY 110,515$4,373,0000.99%
Ghost Tree Capital, LLC 35,000$1,385,0000.75%
WALL STREET ASSOCIATES 159,100$6,296,0000.65%
BAILARD, INC. 91,500$3,621,0000.56%
EAM Investors, LLC 62,768$2,484,0000.50%
View complete list of ENANTA PHARMACEUTICALS INC shareholders